Cinnamaldehyde Analogues as Potential Therapeutic Agents
Bang-Jiao Chen, Chun-Sheng Fu, Guo-Hui Li
1School of Pharmaceutical Sciences, Shandong University, 44 West Wenhua Road, Jinan 250012, P.R. China.
Cinnamaldehyde analogues, including natural compounds like trans-cinnamaldehyde, show promise as anti-cancer and anti-inflammatory agents. Research focuses on synthesizing new analogues for enhanced therapeutic potential and drug development.
Area of Science:
- Medicinal Chemistry
- Pharmacology
- Organic Chemistry
Background:
- Cinnamaldehyde analogues are derived from cinnamaldehyde, featuring a cinnamoyl moiety.
- Their α,α-unsaturated carbonyl pharmacophore acts as a Michael acceptor, enabling electrophilic reactions with biological targets.
- Naturally occurring trans-cinnamaldehyde (CA), 2-benzoyloxycinnam-aldehyde (2-BCA), and 2-hydroxycinnamaldehyde (2-HCA) exhibit significant anti-cancer and anti-inflammatory properties.
Purpose of the Study:
- To review the phytochemical and pharmacological profiles of natural cinnamaldehyde analogues.
- To highlight synthetic cinnamaldehyde derivatives with potent bioactivity.
- To discuss the therapeutic potential and drug development prospects of these compounds.
Main Methods:
- Literature review of phytochemical and pharmacological studies.
- Analysis of chemical structures and their relation to bioactivity.
- Summary of synthetic strategies and modifications.
Main Results:
- Natural cinnamaldehyde analogues possess notable anti-cancer and anti-inflammatory effects.
- Synthetic modifications have yielded analogues with improved potency and druggability.
- Diverse pharmacological functions are linked to the electrophilic nature of the pharmacophore.
Conclusions:
- Cinnamaldehyde analogues represent a promising class of therapeutic agents.
- Further research into synthesis and modification can optimize their medicinal applications.
- These compounds hold potential for development into effective anti-cancer and anti-inflammatory drugs.
More Related Videos
07:30A Direct, Regioselective and Atom-Economical Synthesis of 3-Aroyl-N-hydroxy-5-nitroindoles by Cycloaddition of 4-Nitronitrosobenzene with Alkynones
Published on: January 21, 2020
10:25Screening Traditional Chinese Medicine Compounds for Inhibiting UCHL3 Activity Based on Molecular Docking and Deubiquitinating Enzyme Probe Technology
Published on: November 22, 2024
Related Concept Videos
Adrenergic Agonists: Indirect-Acting Agents
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral...
Sedatives and Hypnotics Drugs: Miscellaneous Agents
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Adrenergic Agonists: Direct-Acting Agents
These agents can be classified...
Adrenergic Agonists: Chemistry and Structure-Activity Relationship
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of...
CNS Stimulants: Cocaine, Amphetamines and Cannabinoids
Direct-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
The direct-acting...
